As is becoming routine, the shorters and racketeers are being rewarded with cheap shares and massive fees while shareholders who actually stick with their investments get done over.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025